| Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma … M Kudo, K Ueshima, M Ikeda, T Torimura, N Tanabe, H Aikata, N Izumi, ... Gut 69 (8), 1492-1501, 2020 | 579 | 2020 |
| Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection K Ohata, K Hamasaki, K Toriyama, K Matsumoto, A Saeki, K Yanagi, ... Cancer 97 (12), 3036-3043, 2003 | 428 | 2003 |
| Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma N Yamaguchi, H Isomoto, T Nakayama, T Hayashi, H Nishiyama, K Ohnita, ... Gastrointestinal Endoscopy 73 (6), 1115-1121, 2011 | 380 | 2011 |
| Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population M Nakamura, N Nishida, M Kawashima, Y Aiba, A Tanaka, M Yasunami, ... The American Journal of Human Genetics 91 (4), 721-728, 2012 | 312 | 2012 |
| Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus S Miyazoe, K Hamasaki, K Nakata, Y Kajiya, K Kitajima, K Nakao, ... Official journal of the American College of Gastroenterology| ACG 97 (8 …, 2002 | 273 | 2002 |
| Different mechanisms for anti-tumor effects of low-and high-dose cyclophosphamide Y Motoyoshi, K Kaminoda, O Saitoh, K Hamasaki, K Nakao, N Ishii, ... Oncology reports 16 (1), 141-146, 2006 | 267 | 2006 |
| MicroRNA signatures in Helicobacter pylori‐infected gastric mucosa K Matsushima, H Isomoto, N Inoue, T Nakayama, T Hayashi, ... International journal of cancer 128 (2), 361-370, 2011 | 253 | 2011 |
| Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter A Ido, K Nakata, Y Kato, K Nakao, K Murata, M Fujita, N Ishii, T Tamaoki, ... Cancer Research 55 (14), 3105-3109, 1995 | 251 | 1995 |
| Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product T Nakayama, A Ohtsuru, K Nakao, M Shima, K Nakata, K Watanabe, ... JNCI: Journal of the National Cancer Institute 84 (17), 1349-1354, 1992 | 250 | 1992 |
| Short interfering RNA-directed inhibition of hepatitis B virus replication K Hamasaki, K Nakao, K Matsumoto, T Ichikawa, H Ishikawa, K Eguchi FEBS letters 543 (1-3), 51-54, 2003 | 245 | 2003 |
| Clinicopathological factors associated with clinical outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms H Isomoto, H Nishiyama, N Yamaguchi, E Fukuda, H Ishii, K Ikeda, ... Endoscopy 41 (08), 679-683, 2009 | 244 | 2009 |
| A novel murine model of Graves’ hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor Y Nagayama, M Kita-Furuyama, T Ando, K Nakao, H Mizuguchi, ... The Journal of Immunology 168 (6), 2789-2794, 2002 | 235 | 2002 |
| Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection—association between TGF-β1 polymorphisms and hepatocellular carcinoma K Migita, S Miyazoe, Y Maeda, M Daikoku, S Abiru, T Ueki, K Yano, ... Journal of hepatology 42 (4), 505-510, 2005 | 211 | 2005 |
| Antitumor function of microRNA-122 against hepatocellular carcinoma K Nakao, H Miyaaki, T Ichikawa Journal of gastroenterology 49, 589-593, 2014 | 206 | 2014 |
| A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update R Tateishi, K Uchino, N Fujiwara, T Takehara, T Okanoue, M Seike, ... Journal of gastroenterology 54, 367-376, 2019 | 205 | 2019 |
| MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells K Matsushima, H Isomoto, N Yamaguchi, N Inoue, H Machida, ... Journal of translational medicine 9, 1-12, 2011 | 178 | 2011 |
| Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation M Shigeno, K Nakao, T Ichikawa, K Suzuki, A Kawakami, S Abiru, ... Oncogene 22 (11), 1653-1662, 2003 | 178 | 2003 |
| Significance of serum and hepatic micro RNA‐122 levels in patients with non‐alcoholic fatty liver disease H Miyaaki, T Ichikawa, Y Kamo, N Taura, T Honda, H Shibata, M Milazzo, ... Liver international 34 (7), e302-e307, 2014 | 172 | 2014 |
| Aspirin and NS-398 inhibit hepatocyte growth factor–induced invasiveness of human hepatoma cells S Abiru, K Nakao, T Ichikawa, K Migita, M Shigeno, M Sakamoto, ... Hepatology 35 (5), 1117-1124, 2002 | 163 | 2002 |
| High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection K Ohata, K Hamasaki, K Toriyama, H Ishikawa, K Nakao, K Eguchi Journal of gastroenterology and hepatology 19 (6), 670-675, 2004 | 162 | 2004 |
